
Assistant Professor @YaleMed⏐Human genetics, hematopoiesis & pleiotropy⏐Diabetes, cardiometabolic & neuroimmune disease⏐PI, Alagpulinsa Lab⏐Nature & Freedom⏐
- Tweets3K
- Following326
- Followers391
- Likes4.8K

ALT 🧬 Scientists May Have Found a Way to RESET Autoimmune Diseases Imagine treating lupus, MS, or type 1 diabetes not with lifelong medicine… but by rebooting the immune system itself. Scientists are now using genetically engineered immune cells to hunt down the exact cells causing autoimmune disease. In early trials, some patients experienced complete remission — something once thought impossible. Even more surprising? Many dangerous side effects seen in cancer treatments were missing. If these trials continue to succeed, this breakthrough could change millions of lives forever. Source: Mackensen, A., et al. Nature Medicine. “Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus.”

ALT Flowchart illustrating a diabetes research study. The GRADE study compares diabetes medications: glargine (insulin), glimepiride (sulfonylurea), liraglutide (GLP-1 receptor agonist), and sitagliptin (DPP-4 inhibitor). The chart includes data on physiologic responses and a genome-wide association study. Genetic replication cohorts reference the ORIGIN and SAVOR-TIMI 53 studies. Graphs display results related to glucose tolerance and drug responses in zebrafish models.

ALT This infographic presents findings on sex-specific mortality risk in Type 1 Diabetes during advanced therapeutic care. It details a registry of 4,299 participants with a mortality rate of 131 per 100,000 person-years for those with Type 1 Diabetes, compared to 3.97 for a control group. The relative mortality risk is higher in females with a hazard ratio of 9.0, while for males, it is 2.9. The study spans from 2000-2023 with follow-up data available from 2011-2022.
























